HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model

CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model

(2012) Tam Nguyen-Hoai et al.   JOURNAL OF GENE MEDICINE

DNA vaccination against oncoantigens

(2012) Manuela Iezzi et al.   OncoImmunology

CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model

(2011) T Nguyen-Hoai et al.   CANCER GENE THERAPY

Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector

(2011) Jakub K. Simon et al.   VACCINE

A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle

(2011) Feng Lin et al.   VACCINE

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

(2011) Natalie A Hutnick et al.   Current Opinion in Virology

The dendritic cell–tumor cross-talk in cancer

(2010) Yuting Ma et al.   CURRENT OPINION IN IMMUNOLOGY

Electroporation: A promising method for the nonviral delivery of DNA vaccines in humans?

(2010) L. Frelin et al.   DRUG NEWS & PERSPECTIVES

HER-2/neu as a target for cancer vaccines

(2010) Constantin N Baxevanis et al.   Immunotherapy

Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector

(2010) Takanori Kanazawa et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Langerin+ Dermal Dendritic Cells Are Critical for CD8+ T Cell Activation and IgH  -1 Class Switching in Response to Gene Gun Vaccines

(2010) A. Stoecklinger et al.   JOURNAL OF IMMUNOLOGY

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity

(2010) Daniel E. Speiser et al.   SEMINARS IN IMMUNOLOGY

TLR-based immune adjuvants

(2010) Folkert Steinhagen et al.   VACCINE

Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer

(2008) W. Walther et al.   CLINICAL CANCER RESEARCH

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

(2008) G. E. Peoples et al.   CLINICAL CANCER RESEARCH